315 related articles for article (PubMed ID: 16443707)
1. COPD exacerbations .1: Epidemiology.
Donaldson GC; Wedzicha JA
Thorax; 2006 Feb; 61(2):164-8. PubMed ID: 16443707
[TBL] [Abstract][Full Text] [Related]
2. Lung function impairment, COPD hospitalisations and subsequent mortality.
Garcia-Aymerich J; Serra Pons I; Mannino DM; Maas AK; Miller DP; Davis KJ
Thorax; 2011 Jul; 66(7):585-90. PubMed ID: 21515553
[TBL] [Abstract][Full Text] [Related]
3. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease.
Soler-Cataluña JJ; Martínez-García MA; Román Sánchez P; Salcedo E; Navarro M; Ochando R
Thorax; 2005 Nov; 60(11):925-31. PubMed ID: 16055622
[TBL] [Abstract][Full Text] [Related]
4. Lung function and indicators of exposure to indoor and outdoor particulate matter among asthma and COPD patients.
de Hartog JJ; Ayres JG; Karakatsani A; Analitis A; Brink HT; Hameri K; Harrison R; Katsouyanni K; Kotronarou A; Kavouras I; Meddings C; Pekkanen J; Hoek G
Occup Environ Med; 2010 Jan; 67(1):2-10. PubMed ID: 19736175
[TBL] [Abstract][Full Text] [Related]
5. Chronic obstructive pulmonary disease in the older adult: what defines abnormal lung function?
Mannino DM; Sonia Buist A; Vollmer WM
Thorax; 2007 Mar; 62(3):237-41. PubMed ID: 17090573
[TBL] [Abstract][Full Text] [Related]
6. Is the EQ-5D responsive to recovery from a moderate COPD exacerbation?
Goossens LM; Nivens MC; Sachs P; Monz BU; Rutten-van Mölken MP
Respir Med; 2011 Aug; 105(8):1195-202. PubMed ID: 21439807
[TBL] [Abstract][Full Text] [Related]
7. Inspiratory capacity and forced expiratory volume in the first second in exacerbation of chronic obstructive pulmonary disease.
Yetkin O; Gunen H
Clin Respir J; 2008 Jan; 2(1):36-40. PubMed ID: 20298302
[TBL] [Abstract][Full Text] [Related]
8. Overlap syndrome of asthma and COPD predicts low quality of life.
Kauppi P; Kupiainen H; Lindqvist A; Tammilehto L; Kilpeläinen M; Kinnula VL; Haahtela T; Laitinen T
J Asthma; 2011 Apr; 48(3):279-85. PubMed ID: 21323613
[TBL] [Abstract][Full Text] [Related]
9. [Impact of exacerbations and admissions in chronic obstructive pulmonary disease].
Arnedillo Muñoz A
Arch Bronconeumol; 2010; 46 Suppl 8():8-14. PubMed ID: 21334550
[TBL] [Abstract][Full Text] [Related]
10. Frequent chronic obstructive pulmonary disease exacerbators: how much real, how much fictitious?
Soler-Cataluña JJ; Rodriguez-Roisin R
COPD; 2010 Aug; 7(4):276-84. PubMed ID: 20673037
[TBL] [Abstract][Full Text] [Related]
11. Chronic obstructive pulmonary disease and hospitalizations for pneumonia in a US cohort.
Mannino DM; Davis KJ; Kiri VA
Respir Med; 2009 Feb; 103(2):224-9. PubMed ID: 18945605
[TBL] [Abstract][Full Text] [Related]
12. A 4-year trial of tiotropium in chronic obstructive pulmonary disease.
Tashkin DP; Celli B; Senn S; Burkhart D; Kesten S; Menjoge S; Decramer M;
N Engl J Med; 2008 Oct; 359(15):1543-54. PubMed ID: 18836213
[TBL] [Abstract][Full Text] [Related]
13. Exacerbations and lung function decline in COPD: new insights in current and ex-smokers.
Makris D; Moschandreas J; Damianaki A; Ntaoukakis E; Siafakas NM; Milic Emili J; Tzanakis N
Respir Med; 2007 Jun; 101(6):1305-12. PubMed ID: 17112715
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory changes, recovery and recurrence at COPD exacerbation.
Perera WR; Hurst JR; Wilkinson TM; Sapsford RJ; Müllerova H; Donaldson GC; Wedzicha JA
Eur Respir J; 2007 Mar; 29(3):527-34. PubMed ID: 17107990
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of dynamic hyperinflation parameters and exercise capacity at maximal exercise in patients with COPD].
Ulubay G; Görek A; Savaş S; Oner Eyüboğlu F
Tuberk Toraks; 2005; 53(4):340-6. PubMed ID: 16456732
[TBL] [Abstract][Full Text] [Related]
16. Seasonality and determinants of moderate and severe COPD exacerbations in the TORCH study.
Jenkins CR; Celli B; Anderson JA; Ferguson GT; Jones PW; Vestbo J; Yates JC; Calverley PM
Eur Respir J; 2012 Jan; 39(1):38-45. PubMed ID: 21737561
[TBL] [Abstract][Full Text] [Related]
17. Muscle weakness, health status and frequency of exacerbations in chronic obstructive pulmonary disease.
Ansari K; Keaney N; Taylor I; Burns G; Farrow M
Postgrad Med J; 2012 Jul; 88(1041):372-6. PubMed ID: 22388793
[TBL] [Abstract][Full Text] [Related]
18. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease.
Donaldson GC; Seemungal TA; Bhowmik A; Wedzicha JA
Thorax; 2002 Oct; 57(10):847-52. PubMed ID: 12324669
[TBL] [Abstract][Full Text] [Related]
19. The role of patient-centered outcomes in the course of chronic obstructive pulmonary disease: how long-term studies contribute to our understanding.
Tashkin DP
Am J Med; 2006 Oct; 119(10 Suppl 1):63-72. PubMed ID: 16996901
[TBL] [Abstract][Full Text] [Related]
20. The prevalence of chronic obstructive pulmonary disease in Maastricht, the Netherlands.
Vanfleteren LE; Franssen FM; Wesseling G; Wouters EF
Respir Med; 2012 Jun; 106(6):871-4. PubMed ID: 22349067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
